|
Product class:
|
Authorized package
|
|
Medicinal product class:
|
Veterinary medicine
|
|
Package code:
|
1115457
|
|
Name of medicinal product:
|
Dinolytic
|
|
Active substances:
|
|
|
ATC code:
|
QG02AD01
|
|
Dosage form:
|
solution for injection
|
|
Route of administration:
|
intramuscular use
|
|
Strengh:
|
5mg 1ml
|
|
Amount in package:
|
10ml 1TK
|
|
Legal status for supply*:
|
Subject to medicinal prescription
|
|
Class of active substance:
|
|
|
Additional information:
|
|
|
Indication:
|
Lutalyse is indicated for its luteolytic and/or oxytocic effects in cattle, horses and pigs. The indications for use are:
Cattle
1. To more effectively control the time of oestrus in cycling cows.
2. To treat cows which have a functional corpus luteum, but do not express behavioural oestrus (sub-oestrus or silent heat).
3. To induce abortion.
4. To induce parturition.
5. For treatment of chronic metritis and pyometra.
6. For controlled breeding in normally-cycling dairy cows:
- oestrus synchronisation
- ovulation synchronisation in combination with GnRH or GnRH analogues as part of fixed time artificial insemination protocols.
Mares
1. To more effectively control the time of oestrus in cycling mares.
2. To treat mares which have a functional corpus luteum but do not express behavioural oestrus.
3. To induce abortion.
Pigs
1. Induction of parturition
2. To reduce the weaning to oestrus interval (WOI) and the weaning to fertile service interval (WFSI) in sows in herds with reproductive problems.
|
|
Safety features:
|
No
|
|
Summary of product characteristics (SPC):
|
 (last updated December 31, 2020)
|
|
Package information leaflet (PIL):
|
EST (last updated December 31, 2020)
|
|
Labelling:
|
(last updated December 31, 2020)
|
|
Withdrawal time:
|
Lihale ja söödavatele kudedele: 2 päeva.
Piimale: 0 tundi.
Ei ole lubatud kasutamiseks hobustel, kelle liha tarvitatakse inimtoiduks.
|
|
Species:
|
veis, siga, hobune
|
|
Last imported to Estonia:
|
February 27, 2007
|
|
Marketing authorization holder:
|
Zoetis Belgium
|
|
Marketing authorization number:
|
1319
|
|
Marketing authorization issued on:
|
July 8, 2005
|
|
Marketing authorization expires on:
|
Unlimited
|
|
Marketing authorization procedure type:
|
National
|
Entry/Changing date:
December 31, 2020
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader fromhere